EMEA-002258-PIP01-17

Key facts

Active substance
Recombinant human epidermal growth factor
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0038/2018
PIP number
EMEA-002258-PIP01-17
Pharmaceutical form(s)
Powder and solvent for solution for injection
Condition(s) / indication(s)
Treatment of diabetic foot ulcer
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Praxis Pharmaceuticals S.A
Tel. +436643564874
E-mail: j.rogan@inphares.net
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating